WHO ICTRP trial
An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a…
NL-OMON34416 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON34416 |
|---|---|
| Public title | An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects with Intra-abdominal Infections - A Multicentre, Randomized, Double-Blind Study |
| Scientific title | An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects with Intra-abdominal Infections - A Multicentre, Randomized, Double-Blind Study - INTENSE |
| Primary sponsor | Astellas Pharma B.V. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Austria;Belgium;Denmark;Finland;France;Germany;Greece;Hungary;Israel;Italy;Norway;Poland;Romania;Russian Federation ;Spain;Switzerland;Turkey;United Kingdom |
| Conditions | Invasive Candidiasis caused by intra-abdominal infections; fungal infections that entered your body;10017528;Invasive Candidiasis caused by intra-abdominal infections; fungal infections that entered your body |
| Interventions | The subjects will be entered into the study for 4 months. All participants will start with the pre-emptive treatment (Mycamine or placebo) for their condition for at least 1 day and a maximum of 6 weeks. The subject will receive the study… |
| Registration date | Mar 1, 2011 |
| Target size | 20 |
| Secondary IDs | 2008-006409-18;NCT01122368;NL33282.056.10 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: